Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography | 8 | 2024 | 6001 | 1.520 |
Why?
|
Musculoskeletal System | 4 | 2024 | 188 | 1.100 |
Why?
|
Rheumatology | 4 | 2023 | 619 | 0.840 |
Why?
|
Chondrocalcinosis | 4 | 2023 | 84 | 0.760 |
Why?
|
Musculoskeletal Diseases | 2 | 2024 | 601 | 0.720 |
Why?
|
Osteoarthritis, Knee | 2 | 2022 | 1255 | 0.680 |
Why?
|
Point-of-Care Systems | 4 | 2024 | 1240 | 0.600 |
Why?
|
Peroneal Nerve | 1 | 2014 | 80 | 0.460 |
Why?
|
Nerve Compression Syndromes | 1 | 2014 | 160 | 0.420 |
Why?
|
Curriculum | 5 | 2020 | 3782 | 0.390 |
Why?
|
Calcium Pyrophosphate | 4 | 2023 | 55 | 0.370 |
Why?
|
Calcinosis | 3 | 2023 | 1481 | 0.350 |
Why?
|
Schools, Medical | 1 | 2016 | 882 | 0.340 |
Why?
|
Decompression, Surgical | 1 | 2014 | 610 | 0.320 |
Why?
|
Hospice Care | 1 | 2016 | 679 | 0.310 |
Why?
|
Ultrasonic Therapy | 3 | 2007 | 217 | 0.290 |
Why?
|
Medical Order Entry Systems | 1 | 2013 | 523 | 0.290 |
Why?
|
Pain | 1 | 2022 | 5100 | 0.270 |
Why?
|
Ultrasonography, Interventional | 4 | 2022 | 1524 | 0.270 |
Why?
|
Gout | 2 | 2024 | 621 | 0.270 |
Why?
|
Ultrasonography, Doppler | 3 | 2017 | 463 | 0.250 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 797 | 0.250 |
Why?
|
Leiomyoma | 3 | 2007 | 644 | 0.240 |
Why?
|
Glucocorticoids | 1 | 2013 | 2167 | 0.210 |
Why?
|
Synovitis | 1 | 2024 | 217 | 0.210 |
Why?
|
Sulfonylurea Compounds | 1 | 2024 | 220 | 0.200 |
Why?
|
Uterine Neoplasms | 3 | 2007 | 1424 | 0.180 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 288 | 0.180 |
Why?
|
Arthritis, Rheumatoid | 3 | 2024 | 3780 | 0.180 |
Why?
|
Palliative Care | 1 | 2016 | 3644 | 0.180 |
Why?
|
Calcium | 1 | 2013 | 5792 | 0.170 |
Why?
|
Adrenal Cortex Hormones | 2 | 2022 | 1893 | 0.170 |
Why?
|
Microcirculation | 1 | 2024 | 1281 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Arthritis | 1 | 2024 | 684 | 0.160 |
Why?
|
Vitamin D | 1 | 2013 | 3311 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.160 |
Why?
|
Polymyalgia Rheumatica | 1 | 2018 | 52 | 0.150 |
Why?
|
Giant Cell Arteritis | 1 | 2022 | 307 | 0.150 |
Why?
|
Spondylarthropathies | 1 | 2017 | 14 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1617 | 0.150 |
Why?
|
Uric Acid | 1 | 2024 | 806 | 0.150 |
Why?
|
Arthritis, Reactive | 1 | 2017 | 20 | 0.140 |
Why?
|
Knee Joint | 2 | 2022 | 1685 | 0.130 |
Why?
|
Arthritis, Psoriatic | 1 | 2018 | 219 | 0.130 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2017 | 297 | 0.120 |
Why?
|
Clinical Competence | 4 | 2020 | 4859 | 0.120 |
Why?
|
Humans | 37 | 2024 | 768887 | 0.120 |
Why?
|
Ovarian Diseases | 1 | 2005 | 137 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 610 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.110 |
Why?
|
Synovial Membrane | 1 | 2017 | 536 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 756 | 0.110 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2422 | 0.110 |
Why?
|
Medication Systems | 1 | 2013 | 31 | 0.110 |
Why?
|
Tendons | 1 | 2017 | 557 | 0.110 |
Why?
|
Pelvic Pain | 1 | 2005 | 300 | 0.110 |
Why?
|
Body Temperature | 1 | 2006 | 781 | 0.110 |
Why?
|
Menstrual Cycle | 1 | 2006 | 546 | 0.100 |
Why?
|
Pain Measurement | 2 | 2014 | 3585 | 0.100 |
Why?
|
Internship and Residency | 3 | 2019 | 5956 | 0.100 |
Why?
|
Electronic Prescribing | 1 | 2013 | 115 | 0.100 |
Why?
|
Ovary | 1 | 2005 | 965 | 0.090 |
Why?
|
Lyme Disease | 1 | 2017 | 630 | 0.090 |
Why?
|
Menopause | 1 | 2019 | 1656 | 0.090 |
Why?
|
Middle Aged | 17 | 2024 | 223740 | 0.090 |
Why?
|
Physical Examination | 1 | 2016 | 1262 | 0.090 |
Why?
|
Pain Perception | 1 | 2011 | 198 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2024 | 65485 | 0.080 |
Why?
|
Postmenopause | 1 | 2019 | 2519 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1260 | 0.080 |
Why?
|
Neoplasms | 3 | 2024 | 22390 | 0.080 |
Why?
|
Abdominal Pain | 1 | 2005 | 1070 | 0.080 |
Why?
|
Adult | 12 | 2024 | 223818 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2006 | 1006 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4755 | 0.080 |
Why?
|
Brachytherapy | 1 | 2005 | 1224 | 0.070 |
Why?
|
Antirheumatic Agents | 2 | 2024 | 1381 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3421 | 0.070 |
Why?
|
Female | 18 | 2024 | 397464 | 0.070 |
Why?
|
Aged | 11 | 2024 | 171790 | 0.070 |
Why?
|
Male | 17 | 2024 | 365249 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1085 | 0.070 |
Why?
|
Syndrome | 2 | 2023 | 3274 | 0.070 |
Why?
|
Drug Utilization | 1 | 2013 | 1191 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2956 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2007 | 36861 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10869 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26384 | 0.070 |
Why?
|
Hospitalization | 2 | 2023 | 10845 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3782 | 0.060 |
Why?
|
United States | 6 | 2023 | 73180 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 265 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1673 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7956 | 0.050 |
Why?
|
Osteoporosis | 1 | 2013 | 1606 | 0.050 |
Why?
|
Students, Medical | 1 | 2016 | 1964 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8742 | 0.050 |
Why?
|
Osteoarthritis | 1 | 2010 | 1070 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1206 | 0.050 |
Why?
|
Temporal Arteries | 1 | 2022 | 155 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3214 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3811 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59738 | 0.040 |
Why?
|
Wrist Joint | 1 | 2022 | 267 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2277 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 346 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12252 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3442 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2022 | 81892 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 787 | 0.040 |
Why?
|
Asia | 1 | 2020 | 629 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1027 | 0.040 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2024 | 672 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9442 | 0.040 |
Why?
|
Sweating | 1 | 2017 | 155 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39394 | 0.030 |
Why?
|
Transducers | 1 | 2017 | 245 | 0.030 |
Why?
|
Torsion Abnormality | 1 | 2005 | 92 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2024 | 1890 | 0.030 |
Why?
|
Synovial Fluid | 1 | 2017 | 393 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2663 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13510 | 0.030 |
Why?
|
China | 1 | 2020 | 2395 | 0.030 |
Why?
|
Cough | 1 | 2017 | 598 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3441 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2017 | 702 | 0.030 |
Why?
|
Eosinophilia | 1 | 2017 | 556 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 24330 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 11229 | 0.030 |
Why?
|
Fibromyalgia | 1 | 2017 | 407 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3124 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3858 | 0.020 |
Why?
|
Premenopause | 1 | 2006 | 1039 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6991 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3438 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3110 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54950 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2010 | 129 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41800 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1352 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1263 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2570 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2011 | 1002 | 0.020 |
Why?
|
Administration, Topical | 1 | 2010 | 704 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8888 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8559 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9375 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6673 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12469 | 0.020 |
Why?
|
Linear Models | 1 | 2006 | 5890 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 60110 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3925 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4207 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20244 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6569 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12093 | 0.010 |
Why?
|
Patient Preference | 1 | 2011 | 947 | 0.010 |
Why?
|
Biopsy | 1 | 2005 | 6805 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13677 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13317 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13020 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4042 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
Melanoma | 1 | 2018 | 5709 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22294 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11934 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5864 | 0.010 |
Why?
|
Lung | 1 | 2017 | 10097 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7472 | 0.010 |
Why?
|
Health Status | 1 | 2010 | 4095 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20776 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13593 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10397 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15955 | 0.010 |
Why?
|
Child | 1 | 2017 | 80969 | 0.000 |
Why?
|
Adolescent | 1 | 2017 | 89247 | 0.000 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(79)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_